HomeAnswersMedical GastroenterologyudilivCan I take Udiliv continuously for decreasing SGPT levels?

Is it advisable to take Udiliv continuously to lower SGPT levels?

Share

The following is an actual conversation between an iCliniq user and a doctor that has been reviewed and published as a Premium Q&A.

Answered by

Dr. Ajeet Kumar

Medically reviewed by

Dr. Divya Banu M

Published At July 28, 2020
Reviewed AtAugust 21, 2023

Patient's Query

Hello doctor,

I have a chronic hepatitis B carrier stage. Last year, my DNA count was approximately ten. However, my SGPT level usually hovers around 100. I have noticed that my SGPT decreases when I take the tablet containing Ursodeoxycholic acid, and it rises again if I discontinue it. Could you kindly advise whether I should continue taking the Ursodeoxycholic acid tablet consistently?

Answered by Dr. Ajeet Kumar

Hello,

Welcome to icliniq.com.

I read your query and understood your concern. First of all, it is not very wise to start and stop the medicines like Ursodeoxycholic acid because the medications like it (hepatoprotective agent) are at times the last resort of treatment. Starting and stopping medicines while only measuring SGPT (serum glutamic pyruvic transaminase) levels and not DNA (deoxyribonucleic acid) and other liver tests, can potentially increase the resistance to such drugs. Since you have stopped the treatment at the moment, it is an opportunity to check complete liver studies and HBV (hepatitis B) values, before second time starting the treatment. I suggest you some testing, kindly get them done, or if already done recently, just upload the laboratory test results. I suggest you consult a specialist, talk with them and take the medications with their consent. I hope this has helped you. Kindly follow up if you have more doubts.

Thank you.

The Probable causes

The Probable cause is chronic HBV infection.

Investigations to be done

Complete blood count (CBC), Serum Creatinine, Sodium, Potassium, Hepatitis B Surface Antigen (HbsAg), Hepatitis B e Antigen (HbeAg), Hepatitis B e Antibody (HbeAb), Hepatitis B Virus DNA quantitative, Anti-Hepatitis C Virus (HCV), Liver Function tests (LFTs) Serum Albumin, Serum Alpha-fetoprotein (AFP), Ultrasound of the abdomen, Transient elastography (Fibroscan) of the liver.

Patient's Query

Thanks doctor for the reply.

I have undergone an HBV (Hepatitis B virus) DNA test as per the advised recommendation, and I have attached the report. The results are as follows:

  1. HbeAg: Negative.
  2. HBV DNA quantitative: 75,282 IU/mL.

My HBV DNA level was only 64 IU/mL a year ago, and all other parameters were within the normal range. Kindly advice on whether any treatment is recommended in this situation.

Answered by Dr. Ajeet Kumar

Based on your test results, I suggest you initiate the treatment with a tablet of Tenofovir 300 mg once daily. This antiviral therapy will help regulate your HBV infection. There is no treatment available to completely cure HBV infection. While various medications can effectively control viral replication and provide optimal management, they cannot entirely eliminate the virus from the body. Hence, treatment is typically required for the long term, with exceptions for specific situations where treatment can be halted after careful reassessment. This medication might have certain side effects, including the risk of kidney injury. However, such instances are infrequent and can be managed if detected by discontinuing tenofovir and switching to an alternative antiviral therapy. I would also like to inquire if you have any concerns about the cost. There is an alternative medication called Tenofovir Alafenamide, which comes in a 25 mg dose. It is a refined form of Tenofovir with the same effectiveness and a more favorable side effect profile. However, be aware that this drug might not be universally accessible and can be expensive. In any case, beginning treatment is necessary. Furthermore, I would require additional tests to ensure your kidney function is satisfactory. I hope this has helped you. Kindly follow up if you have more doubts.

Thank you.

The Probable causes

Chronic active Hepatitis B infection in the immunoactive phase.

Investigations to be done

Blood Urea Nitrogen (BUN), Creatinine, Electrolytes. Ultrasound of the abdomen and a Serum Alpha-fetoprotein (AFP) test in our previous consultation.

Treatment plan

A tablet of Tenofovir 300 mg once daily till advised to stop.

Regarding follow up

Follow up after the initiation of the medication.

Patient's Query

Thanks for the reply doctor.

Last year, I was in the inactive carrier stage of hepatitis B. Has my condition now transitioned to the active stage? I would prefer to use Tenofovir Alafenamide. Could you provide me with an estimate of its price range? I have undergone the other tests as prescribed. However, I could not get the Serum Alpha-fetoprotein (AFP) test done since it is not available in my town. Kindly suggest.

Answered by Dr. Ajeet Kumar

Hello,

Welcome back to icliniq.com.

I read your query and understood your concern. Firstly, I would like to inform you that, the challenge with hepatitis B infection is that it has a tendency to persist within the body. The virus can rapidly replicate, leading to an increase in the DNA value. The virus progresses through four stages as mentioned below:

  1. HbeAg positive and Immunotolerant phase.
  2. HbeAg Immunoreactive phase.
  3. HbeAg negative immunotolerant phase (carrier stage).
  4. HbeAg Immunoactive phase.

You are currently in the HbeAg negative immunoactive phase. Last year, you were in the HbeAg negative Immunotolerant phase. Traditionally, treatment was reserved for immunoactive phases. However, nowadays, antiviral therapies are administered across all four stages due to accumulating evidence and research supporting this approach. It is good that you have decided to initiate Tenofovir Alafenamide 25 mg once daily. You can inquire at your local pharmacy for the available brand in your country of residence. I have also reviewed your reports (attachments removed to protect the patient’s identity), and they appear to be within normal ranges. While your AFP is important, I suggest you undergo the test whenever feasible, as it holds significant importance. Once you have conducted the AFP test, kindly follow up with me. Additionally, another follow-up should occur after three months of taking Tenofovir Alafenamide. This follow-up should include the following tests:

  1. Alpha-fetoprotein (AFP)
  2. Complete Blood Count (CBC).
  3. Serum SGPT: Serum Alanine Aminotransferase (SGPT).
  4. Serum SGOT: Serum Aspartate Aminotransferase (SGOT).
  5. HBV DNA quantitative PCR: Hepatitis B Virus DNA quantitative Polymerase Chain Reaction.

I suggest you consult a specialist, talk with them and take the medications with their consent. I hope this has helped you. Kindly follow up if you have more doubts.

Thank you.

Investigations to be done

Serum Alpha-fetoprotein AFP (in a week or two). After three months - Complete blood count, Serum SGPT, serum SGOT, and HBV DNA quantitative PCR.

Regarding follow up

Follow up as advised

Same symptoms don't mean you have the same problem. Consult a doctor now!

Dr. Ajeet Kumar
Dr. Ajeet Kumar

Medical Gastroenterology

Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Read answers about:

sgptudiliv

Ask your health query to a doctor online

Medical Gastroenterology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy